IRONWOOD PHARMACEUTICALS INC
A healthcare company developing and commercializing therapies for GI diseases.
IRWD | US
Overview
Corporate Details
- ISIN(s):
- US46333X1081
- LEI:
- Country:
- United States of America
- Address:
- 100 SUMMER STREET, SUITE 2300, 2110 BOSTON
- Website:
- https://www.ironwoodpharma.com/
- Sector:
- Manufacturing
Description
Ironwood Pharmaceuticals is a gastrointestinal (GI)-focused healthcare company dedicated to advancing the treatment of GI diseases and redefining the standard of care for patients. The company's core activities involve the development and commercialization of innovative therapies that target GI conditions. Its primary commercial product, LINZESS® (linaclotide), is a prescription medication for adults with irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Leveraging its singular focus and deep expertise in the GI field, Ironwood Pharmaceuticals also maintains a pipeline of potential new treatments to address significant unmet patient needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all IRONWOOD PHARMACEUTICALS INC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IRONWOOD PHARMACEUTICALS INC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IRONWOOD PHARMACEUTICALS INC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
